May 29, 2025
In a secondary analysis of phase 2b spesolimab data in generalized pustular psoriasis (GPP), nearly two-thirds of patients who received 300 mg monthly doses maintained clear […]
May 29, 2025
TOPLINE: A recent study found that patients with psoriasis showed better adherence to a Mediterranean-style diet but a higher consumption of processed foods than participants without […]
May 29, 2025
TOPLINE: In patients with chronic vulvar complaints, allergic contact dermatitis (ACD) shows high prevalence with 86.6% exhibiting positive patch test reactions, of which 37.9% were clinically […]
May 29, 2025
TOPLINE: Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a systematic review. METHODOLOGY: Researchers conducted a systematic review […]
May 29, 2025
Growing evidence suggested that the skin and gut may be more closely linked than once thought — especially in chronic inflammatory conditions like rosacea. In a […]
May 28, 2025
TOPLINE: A randomized trial showed quantitative differences between four botulinum toxin A formulations among women treated for glabellar rhytids, with abobotulinum toxin A (ABoNT/A) and prabotulinum […]
May 28, 2025
ORLANDO, Fla. — For years, fully ablative laser skin resurfacing — in which the epidermis is removed using carbon dioxide or erbium lasers — fell out […]
May 26, 2025
TOPLINE: A study found that fourth-generation progestins in oral contraceptive pills (OCPs) were associated with more than double the risk for melasma than with no exposure, […]
May 22, 2025
The foam formulation of the phosphodiesterase-4 (PDE4) inhibitor roflumilast has been approved by the US Food and Drug Administration (FDA) for treating plaque psoriasis of the […]